Alaunos Therapeutics enters $25M equity purchase agreement with Mast Hill Fund

Alaunos Therapeutics, Inc.

Mast Hill commits to buy up to $25M of common stock over 24 months at Company's discretion.
Company issued warrant to Mast Hill for 79,900 shares at $4.00 exercise price, 5-year term.
Minimum put $5K, max $500K per put or 20% of 5-day avg trading volume.
Shares subject to 4.99% beneficial ownership cap and Nasdaq 19.99% exchange cap unless stockholder approval.
Registration rights agreement requires filing registration statement within 60 days.

item 1.01item 3.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.